PAINWeek 2023 Abstract
Source: Krishnan R, Skerrett D, Ahuja M, Duiker M, Sheehan M, Imperiale M
September 5, 2023
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Paradigm Biopharmaceuticals a question about this update.